Citius Oncology Inc. (CTOR)
Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
0. 77
+0.02
+2.9491%
$
78.09M Market Cap
- P/E Ratio
- Div Yield
11,700 Volume
- Eps
$ 0.75
Previous Close 
Want to track CTOR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Citius Oncology Inc. (CTOR) Statistics
Valuation metrics
Market Cap 78.09M
Enterprise value 65.05M
Trailing P/E (ttm) -1.61
Forward P/E -
PEG ratio 0.04
Price/Sales (ttm) 10.05
Price/Book (mrq) 2.05
Enterprise Value/Revenue 9.15
Enterprise Value/EBITDA -1.51
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 55.98K
Average volume (90 days) 102.94K
Price summary
52-Week low 0.49
52-Week high 2.25
Beta -
50-Day moving average 0.91
200-Day moving average 0.79
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -6.48%
Operating margin -6.66%
Operational effectiveness
Return on assets -0.41%
Return on equity -1.03%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.07
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.43
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.15
Total debt (mrq) -
Total Debt/Equity (mrq) 0.25
Current ratio (mrq) 0.73%
Book value per share (mrq) 0.37
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
